Cases 11 - 20 of 43
InspiRX Inc. v. Lupin Atlantis Holdings SA
as 21-2026
Plaintiff / Appellant:
InspiRX Inc.
Defendant / Appellee:
Lupin Atlantis Holdings SA
BAUSCH HEALTH IRELAND LIMITED et al v. LUPIN LTD. et al
as 1:2021cv11258
Plaintiff:
BAUSCH HEALTH IRELAND LIMITED, SALIX PHARMACEUTICALS, INC. and NORGINE B.V.
Defendant:
LUPIN LTD., LUPIN INC., LUPIN PHARMACEUTICALS, INC. and others
Cause Of Action: 35 U.S.C. § 271
BAUSCH HEALTH IRELAND LIMITED et al v. LUPIN LTD. et al
as 1:2020cv19379
Plaintiff:
BAUSCH HEALTH IRELAND LIMITED, SALIX PHARMACEUTICALS, INC. and NORGINE B.V.
Defendant:
LUPIN LTD., LUPIN INC., LUPIN PHARMACEUTICALS, INC. and others
Cause Of Action: 35 U.S.C. § 271
Biogen International GmbH v. Lupin Atlantis Holdings SA
as 21-1093
Plaintiff / Appellant:
BIOGEN MA INC. and BIOGEN INTERNATIONAL GMBH
Defendant / Appellee:
LUPIN ATLANTIS HOLDINGS SA
Biogen International GmbH v. Amneal Pharmaceuticals LLC
as 21-1078
Defendant / Appellee:
SANDOZ INC., S&B PHARMA, INC., GRAVITI PHARMACEUTICALS PVT. LTD. and others
Plaintiff / Appellant:
BIOGEN INTERNATIONAL GMBH and BIOGEN MA INC.
BAUSCH HEALTH IRELAND LIMITED et al v. LUPIN LTD. et al
as 1:2020cv11039
Plaintiff:
BAUSCH HEALTH IRELAND LIMITED, SALIX PHARMACEUTICALS, INC. and NORGINE B.V.
Defendant:
LUPIN LTD., LUPIN INC., LUPIN PHARMACEUTICALS, INC. and others
Cause Of Action: 35 U.S.C. § 271
Vifor Fresenius Medical Care Renal Pharma Ltd. et al v. Lupin Atlantis Holdings SA et al
as 1:2020cv00911
Defendant:
Teva Pharmaceuticals USA, Inc., Lupin Pharmaceuticals, Inc., Lupin Atlantis Holdings SA and others
Plaintiff:
Vifor Fresenius Medical Care Renal Pharma Ltd. and Vifor Fresenius Medical Care Renal Pharma France S.A.S.
Cause Of Action: 35 U.S.C. § 271
Vifor Fresenius Medical Care Renal Pharma Ltd. et al v. Lupin Atlantis Holdings SA et al
as 1:2020cv00697
Defendant:
Lupin Atlantis Holdings SA, Lupin Limited and Lupin Pharmaceuticals, Inc.
Plaintiff:
Vifor Fresenius Medical Care Renal Pharma Ltd. and Vifor Fresenius Medical Care Renal Pharma France S.A.S.
Cause Of Action: 35 U.S.C. § 271
InspiRX Inc. v. Lupin Atlantis Holdings SA
as 1:2020cv03214
Defendant:
Lupin Atlantis Holdings SA
Plaintiff:
InspiRX Inc.
Cause Of Action: 28 U.S.C. § 1332 bc
In re: Auryxia (Ferric Citrate) Patent Litigation
as 1:2019md02896
Not Classified By Court:
Chemo Research S.L., Insud Pharma S.L., Teva Pharmaceuticals USA, Inc. and others
Counter Defendant:
Keryx Biopharmaceuticals, Inc., Panion & BF Biotech, Inc. and Chen Hsing Hsu
Counter Claimant:
Lupin Atlantis Holdings SA and Lupin Ltd.
In Re:
In re: Auryxia (Ferric Citrate) Patent Litigation
Cause Of Action: 35 U.S.C. § 271
Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.
